Acute viral infection accelerates neurodegeneration in a mouse model of ALS
Open Access
- 29 August 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
While several viral infections have been associated with amyotrophic lateral sclerosis (ALS), the mechanism(s) through which they promote disease remains elusive. Here we investigate the impact of common, acute viral infections on ALS disease onset and progression in the SOD1G93A mouse model. A single sublethal infection prior to onset of ALS clinical signs is associated with markedly accelerated ALS disease progression characterized by rapid loss of hindlimb function. Prior infection results in gliosis in the lumbar spine and upregulation of transcriptional pathways involved in inflammatory responses, metabolic dysregulation, and muscular dysfunction. Therapeutic suppression of gliosis with an anti-inflammatory small molecule, or administration of a direct-acting antiviral, is associated with significantly improved ALS clinical signs, akin to what is observed in uninfected animals. Our study provides causal and mechanistic evidence that the immune response elicited by acute viral infections may be an important etiological factor that alters ALS disease trajectory.Keywords
All Related Versions
Funding Information
- ALS Society of Canada
This publication has 88 references indexed in Scilit:
- Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and manExperimental Neurology, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Sexual differences in onset of disease and response to exercise in a transgenic model of ALSNeuromuscular Disorders, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null miceNeurobiology of Disease, 2003
- Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALSAnnals of Neurology, 2002
- Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral SclerosisNeurobiology of Disease, 2002
- Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in miceNature, 2002
- Immune reactivity in a mouse model of familial ALS correlates with disease progressionNeurology, 2001
- Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's diseaseBrain Research, 1998